Bracing for the biosimilar wave

被引:0
|
作者
Asher Mullard
机构
关键词
D O I
10.1038/nrd.2017.36
中图分类号
学科分类号
摘要
The regulatory uncertainty around biosimilars in the United States is finally lifting, just months after the first biosimilar monoclonal antibody hit the US market.
引用
收藏
页码:152 / 154
页数:2
相关论文
共 50 条